Repaglinide 500microgram tablets
BNF presentation 0601023R0AAAAAA within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0601023R0AAAAAA
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
3,755
NHS spend (£)
£10,632.45
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 455 |
| February 2025 | 5 |
| December 2024 | 129 |
| November 2024 | 508 |
| October 2024 | 472 |
| September 2024 | 5 |
| August 2024 | 77 |
| July 2024 | 534 |
| May 2024 | 119 |
| July 2021 | 229 |
| June 2021 | 150 |
| December 2020 | 468 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 55 | No data available |
| Unknown pharmacy | 48 | No data available |
| Unknown pharmacy | 42 | No data available |
| Unknown pharmacy | 33 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 25 | No data available |
| Unknown pharmacy | 25 | No data available |
| Unknown pharmacy | 24 | No data available |
| Unknown pharmacy | 23 | No data available |
| Unknown pharmacy | 23 | No data available |